This highly conserved protein is largely overlooked by researchers but is at the core of immune functions, helping regulate ...
MA’s ZEPHYR Phase 2 trial in schizophrenia Last patient visit completed for ML-004’s IRIS Phase 2 trial in autism spectrum disorderTopline results from both Phase 2 trials expected by mid-August 2026 ...
Abstract: This paper investigates Binary-Phase Shift Keying (BPSK) based Time-Domain Single Carrier Index Modulation (TDSC-IM) optical signaling for next generation very high speed Passive Optical ...
Is there really any need to fork out for a hardware synth these days? We place a trio of hardware classics up against some ...
Researchers at KRISS observed water’s rapid freeze–melt cycles under ultrahigh pressure and discovered Ice XXI, the first new ice phase found in decades. Using advanced high-pressure tech and ...
Company Plans to Initiate First-in-Human Phase 1/2 Trial in 1H 2026, Anchored by a Leading U.S. Academic Medical ...
Discusses Modulation and Combination Strategies in ER-Positive Metastatic Breast Cancer and the Role of Lasofoxifene April 29, ...
PowerHome is a manufacturer and global supplier of power conversion equipment, specializing in single-phase and three-phase ...
EPC’s evaluation kit for a three-phase inverter platform based on its Gen-7 EPC2366 eGaN power transistor streamlines motor ...
The Phase 1/2 FUNCTION-DMD study will enroll ambulatory patients and is designed to evaluate safety, tolerability, and efficacy, including dystrophin protein expression and functional outcomes. "The ...
Researchers at Skoltech have developed an ultra-compact electro-optic modulator based on silicon photonics and plasmonics ...
Kestrel Therapeutics Inc. (“Kestrel” or the “Company”), a clinical stage biotechnology company developing next-generation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results